Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patients.

about

The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy.Dose- and time-dependence of the host-mediated response to paclitaxel therapy: a mathematical modeling approach.

P2860

Q47133539-DA9372D0-BD4E-4249-9122-A4F54BCF5F10 Q49636757-BDB8067D-ADD2-4026-97EC-8A45D201685C

P2860

Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patients.

Item

http://www.wikidata.org/entity/Q40383583

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Mathematical optimisation of t ...... all-cell lung cancer patients.

@en

type

Item

label

Mathematical optimisation of t ...... all-cell lung cancer patients.

@en

prefLabel

Mathematical optimisation of t ...... all-cell lung cancer patients.

@en

P1476

Mathematical optimisation of t ...... all-cell lung cancer patients.

@en

P2093

C Faivre

http://www.w3.org/2001/XMLSchema#string

D Barbolosi

http://www.w3.org/2001/XMLSchema#string

F Barlesi

http://www.w3.org/2001/XMLSchema#string

R El Cheikh

http://www.w3.org/2001/XMLSchema#string

P2860

The prognostic value of etoposide area under the curve (AUC) at first chemotherapy cycle in small cell lung cancer patients: a multicenter study of the groupe Lyon-Saint-Etienne d'Oncologie Thoracique (GLOT).

Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study.

Limited small-cell lung-carcinoma - high complete response rate and survival with short intensive chemotherapy and extensive irradiation - results of a pilot-study.

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer.

Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.

Clinical pharmacology of carboplatin administered in combination with paclitaxel.

Intensive chemotherapy of small cell bronchogenic carcinoma.

A phase Ia/Ib clinical trial of metronomic chemotherapy based on a mathematical model of oral vinorelbine in metastatic non-small cell lung cancer and malignant pleural mesothelioma: rationale and study protocol.

Metronomics chemotherapy: time for computational decision support.

P2888

bjc.2016.439

P304

344-348

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2016.439

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28081545

http://www.w3.org/2001/XMLSchema#string

P932

5294490

http://www.w3.org/2001/XMLSchema#string

Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patients.

about

P2860

P2860

Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932